Non-degrading, molecular glue
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
230
NCT06326411
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 9, 2024
Completion: Nov 30, 2029
Loading map...